10 patients with severe refractory hypertension were treated with captopril and frusemide. All patients had uncontrolled blood pressure (mean arterial pressure >140 mm Hg), and 7 had developed accelerated hypertension despite maximum conventional treatment. Captopril and frusemide controlled blood pressure in all 10 patients, without side effects in 9. There was a significant rise in plasma-potassium in 9 patients (1 mmol/l), and hyperkalæmia (plasma-potassium >6 mmol/l) developed in 3 patients despite coincident treatment with frusemide.
Roland Rosmond, Marie‐Christine Chagnon, Göran Holm, Marie‐Christine Chagnon, Louis Pérusse, Kajsa Lindell, Björn Carlsson, Claude Bouchard, Per Björntorp
The Journal of Clinical Endocrinology & Metabolism
Christopher Newton‐Cheh, Chao‐Yu Guo, Philimon Gona, Martin G. Larson, Emelia Benjamin, Thomas J. Wang, Sekar Kathiresan, Christopher J. O’Donnell, Stacy L. Musone, Amy L. Camargo, Jared A. Drake, Daniel Levy, Joel N. Hirschhorn, Ramachandran S. Vasan
Discussion(0)
No comments yet. Be the first to comment.